DFT study explores adsorption and interfacial interactions of TMZ nanocarrier systems, suggesting improved delivery in glioblastoma therapy.
The rapid degradation and limited tumor accumulation of temozolomide (TMZ) remain important challenges in glioblastoma chemotherapy, motivating the development of nanocarrier systems that can improve TMZ retention and delivery. This...
No takes yet. Share an insight, caveat, or question.
Yousuf et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: